FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

762315004: Therapy related acute myeloid leukemia due to and following administration of antineoplastic agent (disorder)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3635334012 Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3636381018 Therapy related acute myeloid leukemia due to and following administration of antineoplastic agent (disorder) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3636382013 Therapy related acute myeloid leukemia due to and following administration of antineoplastic agent en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
7634651000241119 LMA (leucémie myéloïde aigüe) liée à un traitement due à l'administration d'un agent chimiothérapeutique fr Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
7634661000241116 LMA (leucémie myéloïde aigüe) liée à un traitement due à l'administration d'un agent antitumoral fr Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
7634671000241112 leucémie myéloïde aigüe liée à un traitement due à l'administration d'un agent antinéoplasique fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent Due to Administration of antineoplastic agent true Inferred relationship Some 1
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent Is a trouble causé par un médicament false Inferred relationship Some
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent Is a Complication of procedure false Inferred relationship Some
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent Is a séquelle false Inferred relationship Some
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent Is a Complication of chemotherapy (disorder) true Inferred relationship Some
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent Is a Therapy related acute myeloid leukemia and myelodysplastic syndrome (disorder) false Inferred relationship Some
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent After Administration of antineoplastic agent true Inferred relationship Some 2
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent Associated morphology Therapy-related acute myeloid leukemia and myelodysplastic syndrome false Inferred relationship Some 3
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent Causative agent (attribute) Antineoplastic agent (substance) true Inferred relationship Some 3
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent Finding site Bone marrow structure true Inferred relationship Some 3
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent Is a Disorder following clinical procedure false Inferred relationship Some
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent Is a Complication of introduction procedure true Inferred relationship Some
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent Is a Drug-induced lesion true Inferred relationship Some
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent Is a Hematologic complication of procedure true Inferred relationship Some
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent Is a Neoplastic complication of procedure true Inferred relationship Some
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent Is a Therapy-related myelodysplastic syndrome (disorder) true Inferred relationship Some
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent Associated morphology Myeloid neoplasm post cytotoxic therapy (morphologic abnormality) true Inferred relationship Some 3

Inbound Relationships Type Active Source Characteristic Refinability Group
A subgroup of therapy-related myeloid neoplasms (t-MN), associated with a treatment of an unrelated neoplastic or autoimmune disease with cytotoxic agents, like cyclophosphamid, platins, melphalan and others. The neoplastic cells typically harbour unbalanced aberrations of chromosomes 5 and 7 (monosomy 5/del(5q) and monosomy 7/del(7q)) or a complex karyotype. It usually presents with multilineage dysplasia and cytopenias 5-10 years after exposure, with symptoms related to the degree of bone marrow failure and the corresponding cytopenia (fatigue, bleeding and bruising, recurrent infections, bone pain). Is a True Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent Inferred relationship Some

This concept is not in any reference sets

Back to Start